La Jolla, Calif., Jan. 18 /PRNewswire FirstCall/ — Stephen D Ferrone, President and CEO von Immunosyn corporation, which will, which is present to a different group of investors, portfolio managers and analysts at the Flaherty Financial/Wall Street Research Small, covers conference on January 22, 2008 at the Penn Club in New York town center with a cap. Webcast the representation is available and for 60 days at http://www.visualwebcaster.com/event.asp?=42359 archived. “We too present Immunosyn granted privilege for the group of selections of the investors, cover industrial experts and analysts at the Flaherty financial news/Wall Street Research Small conference with a cap,” says Ferrone. “This a large is opportunity increase to market consciousness for Immunosyn to articulate our sight and goals and to show die ways, in those we moving more closer for obtaining it.” Objectives Immunosyns, overview and product information to the target audience with select conferences like the Flaherty Financial/Wall Street Research Small cap conference communicated. Representations are formed, die die include market for data, research information and milestones obtained. As if part concentrated of representation Immunosyns, including Ferrone on biopharmaceutical the SF-1019 and information about die steps, die toward permission by die responsible supervisory authority and results of a new attempt to be taken. Over Flaherty financial news Flaherty is more Newsletter financial news the publisher of the totalelectronic covering of the neglected micro and Kw_smallkappe of markets with Flaherty financial news and Flaherty special situations. Both were discharged recently by “legendary financial publishers” Bob the Flaherty, publishers and chairman von Flaherty financial news Inc. and its son Brian, which President as and serves publisher. For future expenditures please visit http://www.flahertyfinancialnews.com and machine log book inside inside decide. Over WallStreet Research WallStreet Research (WSR) is a managing research fashion shop led by Alan Stone, acting managing director of the Alan of stone and Company, LLC (ASC). The enterprise specializes in die micro and small cap investment arena and looks for emerging growth companies with strong management, singular or own technology, important market potential, financial strength and outstanding long-term incomes growth possibilities. WSR has offices in Los Angeles, in approx., in palm the beach, in flat steel bar and in New York town center, NY. Over Immunosyn corporation La Jolla, CA headquartered Immunosyn corporation (IMYN.OTC.BB) plans to market and distributes the life, which increases therapeutik. Z.Z. has company exclusive world-wide rights of its largest shareholder, Argyll Biotechnologies, LLC, market to, sell and distributes SF-1019, compound, which was developed by the extensive research into biological waiting modifying factors (BRMs). Argyll Biotechnologies, LLC introduced die process for permission by die responsible supervisory authority of SF-1019 in several the countries and preparations for clinical attempts is on the way in US and in Europe Research suggests that SF-1019 has the potential to affect a number from the clinical conditions to die complications of sugar-ill Mellitus like sugar-ill neuropathy (DN) including is and sugar-ill ulcers (YOU), auto immune disturbances like repeated Sklerose (ms) and neurological disturbances like chronic inflammatory Demyelinating the Polyneuropathie (CIDP) and sympatisches Dystrophie Reflexsyndrom (RSD or RSDS). (to more information about Immunosyn and SF-1019 you go too http://www.immunosyn.com), die above news release contains the forward looking of of statements. These statements are based on acceptance the fact that management are die appropriate be based on at present available information and concerning include statements is die intention, the faith or die current expectations of Company believes and its management. Future investors are warned that possibly such forwardlooking statements are not warranties of the future achievement and to wide distance business of the dangers, external factors and uncertainties are subject. Actual results may more differ materially indicated of those by such forwardlooking statements. To additional information please die newest public archivings and annual advise Report the Companys on form 10-K for its newest fiscal year. Kw_Company it accepts that to update die information die in this press will contain no obligation, more whether than result the new information, future cases or differently releases you.
To further information you approach: Bill Kraus/Lisa Baker/Devon Blaine die Blaine group of 310/360 1499 310/360 1498 (FAX) blaine@blainegroupinc.com
.
source
bookmark this post:
Related articles:
A Beginner’s Hand To Mutual Fund Investing.
Coxswain to weigh in on health insurance bills.
Goal date does not finance always best way to strike marking
late purchase wave nasdaqs of the 0,8% sets up profit
Committee on Commerce Corporation Learning Budget.
